期刊文献+

腺苷同型半胱氨酸水解酶的表达纯化及活性测定方法建立

Expression and purification of adenosyl homocysteine hydrolase and establishment of its activity determination method
下载PDF
导出
摘要 目的获得高纯度的重组S-腺苷同型半胱氨酸水解酶(SAHH),并建立其活性测定方法。方法运用基因工程技术,在大肠杆菌系统中原核表达重组SAHH,经过镍亲和层析和Sephadex G15两步纯化,得到目的蛋白对其进行理化性质鉴定,并通过优化活性测定条件,确定SAHH活性测定方法。结果终产物SAHH纯度为95%,相对分子质量为49000,比活性为1615U/mg。在37℃、pH7.5的HEPES缓冲液中反应20min为酶活性测定最佳条件,抑制剂可有效抑制酶活性。结论通过基因重组技术可获得高纯度的SAHH,产物理化性质良好,活性测定方法成功建立,为循环酶法测定同型半胱氨酸工艺稳定放大提供可循依据,并且为SAHH抑制剂科学研究提供一种可靠的方法。 Objective To obtain high purified recombinant S-adenosyl homocysteine hydrolase(SAHH) and establish its activity determination method.Methods Genetic engineering technology was adopted to express recombinant SAHH in E.coli prokaryotic expression system.The target protein was obtained via two-step purification including nickel affinity chromatography and Sephadex G15,and its physical and chemical properties were identified.SAHH activity determination method was established through optimizing the condition of activity measurement.Results The purity of endproducts SAHH was 95% with relative molecular mass of 49 000 and the specific activity of 1 615 U/mg.The condition of 37 ℃,pH7.5 HEPES buffer and 20 minutes' reaction was optimum for SAHH activity determination.SAHH inhibitor effectively inhibited its activity.Conclusion High purified SAHH can be obtained through recombinant genetic technology with good physical and chemical propoties.Successful establishment of its activity determination provide a basis for stable amplification of circulating homocysteine enzymatic measurement technology and a reliable method for scientific research on SAHH inhibitors.
出处 《国际检验医学杂志》 CAS 2013年第12期1500-1502,共3页 International Journal of Laboratory Medicine
基金 国家高技术研究发展计划(863计划)资助项目(2011AA02A111)
关键词 腺苷同型半胱氨酸水解酶 亲和层析 生物活性 DTNB显色 adenosyl homocysteine hydrolase affinity chromatography biological activity DTNB colourtest
  • 相关文献

参考文献11

  • 1陈昕,王琳.S-腺苷-L-高半胱氨酸水解酶及其抑制剂的研究进展[J].中国药物化学杂志,1998,8(1):66-72. 被引量:5
  • 2阮桂芝.同型半胱氨酸在临床诊治中的价值[J].国际检验医学杂志,2010,31(10):1151-1152. 被引量:7
  • 3纪宇,李振涛,朱奇,李爱秀.S-腺苷高半胱氨酸水解酶及其抑制剂的研究近况[J].药学进展,2005,29(11):481-486. 被引量:6
  • 4Lozada-Ramirez JD, Martinez-Martinez I,Garcia-Carmona F, etal. Cloning, overexpression, purification, and characterization of S-adenosylhomocysteine hydrolase from corynebacterium efficiensYS-314[J]. Biotechnol Prog,2008,24(1) :120-127.
  • 5Porcelli M, Fusco S. Inizio T, et al. Expression, purification, andcharacterization of recombinant S-adenosylhomocysteine hydrolasefrom the thermophilic archaeon sulfolobus solfataricus[J]. ProteinExpr Purif,2000,18(1) :27-35.
  • 6张金伟,曾润颖.南极嗜冷假单胞菌7197S-腺苷同型半胱氨酸水解酶(SAHH)基因的克隆与序列分析[J].现代生物医学进展,2006,6(4):5-7. 被引量:3
  • 7Nakanishi M,Iwata A, Yatome C,et al. Purification and propertiesof recombinant plasmodium falciparum S-adenosyl-L-homocys-teine hydrolase[J]. J Biochem,2001,129(1) *.101-105.
  • 8Yuan CS, Ault-Riche DB, Borchardt RT. Chemical modificationand site-directed mutagenesis of cysteine residues in human pla-cental S-adenosylhomocysteine hydrolase[J]. J Biol Chem, 1996 ,271(45):28009-28016.
  • 9Khare P,Gupta AK.Gajula PK,et al. Identification of novel S-ad-enosyl-L-homocysteine hydrolase inhibitors through homology-model-based virtual screening, synthesis, and biological evaluation[J]. J Chem Inf Model,2012,52(3) :777-791.
  • 10Nakanishi M. S-adenosyl-L-homocysteine hydrolase as an attrac-tive target for antimicrobial drugs[J], Yakugaku Zasshi,2007,127(6):977-982.

二级参考文献68

  • 1林念炜,张锐,赵晶,曾润颖.南极产低温蛋白酶菌株Marinobacter sp.R2的发酵条件及酶学性质研究[J].厦门大学学报(自然科学版),2004,43(6):865-869. 被引量:24
  • 2张金伟,曾润颖.南极产低温脂肪酶菌株Psychrobacter sp.7195的选育、发酵条件及酶学性质研究[J].生物磁学,2006,6(1):6-10. 被引量:17
  • 3阴斌霞,王香玲,赵丽华,柴丽华,岳天海,高宁.重症肝炎患者同型半胱氨酸水平观察[J].中华检验医学杂志,2007,30(7):774-777. 被引量:7
  • 4Ramussen K,Moller J,Lyngbak M.Within-Person Variation of plasma homocysteine and effects of posture and toumiquet application[J].Clin Chem;1999,45(10):1850-855.
  • 5Moustapha A.Naso A,Nahlawi M,et al.Prospective study of hyperhomocysteinemia as an adversr cardiovascular risk factor in end-stage renal disease[J].Circulation,1998,97:138-141.
  • 6Wolf M S, Borchardt R T. S-adenosyl-L-homocysteine hydrolase as a target for antiviral chemotherapy [ J ]. J Biol Chem, 1991,34(5) : 1521-1530.
  • 7Yuan C S, Wnuk S F, Robins M J, et al. A novel mechanism-based inhibitor ( 6'-bromo-5', 6'-didehydro-6'-deoxy-6') that eovalently modifies human placeental S-adenosylhomocysteine hydrolase [ J ]. J Biol Chem, 1998, 273(29): 18191-18197.
  • 8Wnuk S F, Mao Y, Yuan C S, et al. Discovery of type Ⅱ(covalent) inactivation of S-adenosylhomocysteine hydrolase involving its "hydrolytic activity": synthesis and evaluation of dihalohomovinyl nucleoside analogues derived from adenosine[J]. J Med Chem, 1998,41(16): 3078-3083.
  • 9De Clercq E. S-adenosyl-L-homocysteine hydrolase in hibitorsas broad-spectntm antiviral agents[ J]. Biochem Pharmacol,1987, 36(16) : 2567-2575.
  • 10Wnuk S F, Yuan C S, Borchardt R T, et al. Nucleic acid related compounds. 84. Synthesis of 6'-( E- and Z )-halohomovinyl derivatives of adenosine, inactivation of S-adenosyl-L-homocysteine hydrolase, and correlation of anticancer and antiviral potencies with enzyme inhibition[ J].J Med Chem, 1994, 37(21): 3579-3587.

共引文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部